©WebNovelPub
Previous chapter:
Chapter 212: Contemplating
Next chapter:
Chapter 214: Reconnection
PREVIEW
... oposed acquisition by Aegis Pharmaceuticals. The conference room was charged with differing opinions, as some board members pointed out the immediate financial gain from the sale, while others raised concerns about the long-term impact on the company’s innovations and independence.
"I think we shouldn’t sell," one board member, Thomas, said firmly. "The potential for growth in our R&D is too great to give up now. We’re on the cusp of breakthroughs that could redefine entire sectors o ...
YOU MAY ALSO LIKE